Trial intelligence / Profile preview

MVAC and Surgery in Stage II Bladder Cancer

NCT00002919Phase 2Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Nov 1996
Primary completion
Jan 2003
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methotrexate, vinblastine, doxorubicin, cisplatin in bladder cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 1996; status: completed.

02

Drugs

methotrexatevinblastinedoxorubicincisplatin
03

Conditions

bladder cancer

Beyond the preview

Go deeper on NCT00002919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call